Zymedyne Therapeutics
Research - Calgary, Alberta, Canada
Zymedyne Therapeutics Employees
Zymedyne Therapeutics Details
Zymedyne aims to develop safer, more effective treatments for chronic, neuropathic pain by targeting human Cav3.2 "T-type" calcium channels that are known to be crucial in pain signalling. Unlike opioids, our technology aims to achieve pain relief without the detrimental side effects of weight gain, respiratory depression and addiction that plague current users of opioid-based medications.
Website:
http://www.zymedyne.ca
Employees:
1
HQ:
Location:
Calgary, Alberta, Canada
Revenue:
Zymedyne Therapeutics Technologies
Widgets
Facebook Widget
CMS
WordPress.org
Social Login
Facebook Login (Connect)
Other
Mobile Friendly